Mentor Worldwide LLC, part of the Johnson & Johnson Medical Devices Companies, announces that the US Food and Drug Administration (FDA) approved the MENTOR MemoryGel BOOST Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.
This product will be commercially available for surgeons in the United States in early 2022.
Nearly 400,000 women undergo breast implant surgeries every year in the US, and selecting an implant is a very personal decision and critical part of the journey. Each patient’s preferences and goals are unique, and that means providing surgeons with a wide range of sizes and profiles to enhance their ability to individualize a patient’s results. While there are many options currently available, surgeons cite the need for an implant with increased form stability to help shape the breast, without sacrificing the soft, natural feel that patients desire.
“Our commitment to innovation is driven, first and foremost, by the needs of our customers and patients, and providing them with the highest quality products to achieve their desired outcome. With this pivotal addition to our MemoryGel portfolio, we are thrilled to provide a meaningful range of options to meet surgeon objectives and patient preferences, beyond what is currently available in the breast aesthetics market.”— Lori Tierney, Worldwide President, Mentor Worldwide LLC
According to a recent survey, patients and surgeons both preferred the MENTOR MemoryGel BOOST Breast Implant as feeling more like a natural breast versus another leading brand.
MemoryGel BOOST brings together Mentor’s proprietary highly cohesive gel, an innovative implant shell design and precision fill ratio, the combination of which provides an implant with increased form stability to shape the breast.
“Through science-based design and innovation, we are able to offer both increased form stability and a natural feel in the same product. The MemoryGel BOOST Breast Implant is truly a unique innovation that satisfies an unmet need and expands the MemoryGel product line.”— Krasimira Hristov, Director of R&D, Mentor Worldwide LLC
[Source(s): Johnson & Johnson Medical Devices Companies, PR Newswire]